As hyperphosphorylated tau is associated with NFTs and tau-related neurodegenerative diseases, inhibition of the responsible kinases has been a top strategy for targeting tau for the prevention or treatment of AD and other tauopathies [162]. The gene discussed is MAPT; the disease is neurodegenerative disease.